Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Analysis of Central Nervous System Tumors

NCT02692898 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02692898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02692898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Analysis of Central Nervous System Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Terminated
Start date
February 25, 2016
Completion date
November 15, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, cancer of the brain, central nervous system neoplasms, neoplasms, brain, primary brain neoplasms